DGOYX
Price
$48.76
Change
-$0.09 (-0.18%)
Updated
Jul 13 closing price
Net Assets
654.39M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

DGOYX vs VSTSX

DGOYX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
DGOYX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGOYX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. DGOYX (654M). VSTSX pays higher dividends than DGOYX: VSTSX (1.07) vs DGOYX (0.88). DGOYX was incepted earlier than VSTSX: DGOYX (29 years) vs VSTSX (10 years). DGOYX (0.69) is less costly to investors than VSTSX (0.01). DGOYX is a more actively managed with annual turnover of: 18.00 vs. VSTSX (3.00). DGOYX has a lower initial minimum investment than VSTSX: DGOYX (5000000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. DGOYX (11.72). VSTSX return over 5 years is better than : 66.56 vs. DGOYX (6.15).
DGOYXVSTSXDGOYX / VSTSX
Total Expense Ratio0.690.016,900%
Annual Report Gross Expense Ratio0.690.016,900%
Fund Existence29 years10 years-
Gain YTD12.27311.205110%
Front LoadN/AN/A-
Min. Initial Investment500000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets654M2.3T0%
Annual Yield % from dividends0.881.0782%
Returns for 1 year11.7221.4855%
Returns for 3 years25.5667.0638%
Returns for 5 years6.1566.569%
Returns for 10 years69.30239.5329%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I